What You Need To Know About Ketamine Therapy
January 27, 2021
Ketamine therapy is for individuals who have tried other forms of treatment that have not achieved success. (And for this reason, it is not typically considered as a first-line treatment.)
A study published in the American Journal of Psychiatry found about one third of patients with depression don’t respond to traditional forms of treatment. An additional study showed when participants with treatment-resistant mood disorders were treated with ketamine, many felt better within four hours of being administered the medicine.
Ketamine infusion therapy is safe when administered by a qualified physician. It can help you feel better sooner and feel better longer too, which is an advantage over traditional forms of treatment.
As with any treatment, there are potential side effects. Common side effects that may occur temporarily during and immediately after treatment include: nausea, dizziness, blurred vision or headaches.
Additionally, patients who receive ketamine therapy are advised to not drive for 24 hours following treatment.
Ketamine therapy should not be administered to individuals with hypertension, heart disease, kidney problems or liver failure.
Physicians have been using ketamine as an off-label treatment for decades. There is strong evidence that supports IV ketamine infusion therapy being beneficial when treating debilitating mood disorders.
When compared to traditional forms of treatment, ketamine infusions can be more effective with rapid, more dramatic results. For those who have lived with mental illness for months or even years, ketamine could be the solution to treatment-resistant conditions.
Want to learn more about IV ketamine infusion therapy?
Contact us via our website or give us a call at (844) 463-8734.
MD Infusions is located in Chicago’s North Shore community of Northbrook. Northbrook is known for its luxurious shopping and dining options, picturesque outdoor scenery and natural vibrancy. It is just 25 miles north from Downtown Chicago.